Dr Sabina Heinz and Victoria Allan

Dr Sabina Heinz, Virology & Liver Diseases Therapy Monitors, Ipsos Healthcare. (T +44 20 3059 5298 E: Sabina.heinz@ipsos.com)Victoria Allan, Cardiovascular/Respiratory Therapy Monitors, Ipsos Healthcare


Who Will Win the Race to Treat NASH?

The liver disease non-alcoholic steatohepatitis (NASH) has become a priority for the healthcare industry – and, potentially, a multi-billion-dollar market. The race is now to develop the first effective pharmacotherapy to treat it.